Photodynamic therapy with verteporfin for retinal angiomatous proliferation

Francesco Boscia, Maurizio Battaglia Parodi, Claudio Furino, Michele Reibaldi, Carlo Sborgia

Research output: Contribution to journalArticle

50 Citations (Scopus)

Abstract

Purpose: The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV). Methods: In this non-comparative, consecutive, interventional, case series, the data on 21 eyes (19 with stage 2 and two with stage 3 RAP) of 20 patients were reviewed. Serous PED occupied more than 50% of the lesion in 19 eyes. PDT was performed as per TAP protocol. Biomicroscopy and fluorescein and indocyanine-green angiography were performed to evaluate anatomical results and need for retreatment. Changes from baseline in best-corrected visual acuity (BCVA), and complications, were assessed. Results: A mean of 3.5±0.9 treatments was performed. After 13.7±2.2 months, mean BCVA decreased from 20/80 to 20/174 (P=0.0063). In six eyes (28.6%) BCVA remained stable, whereas in 15 eyes (71.5%) it decreased. Occlusion of RAP and flattening of PED was observed in three (14.2%) eyes, conversion to disciform lesion in one (4.7%), and persistence of PED in 11 eyes (52.3%). One eye (4.7%) evolved to haemorrhagic PED, and one (4.7%) toward stage 3 RAP. A tear in the retinal pigment epithelium (RPE) was observed in four eyes (19%). Eleven (52.3%) showed progression of leakage, six moderate leakage (28.6%), and three (14.2%) absence of leakage. Conclusions: Timely PDT with verteporfin in the early stages in eyes with smaller lesions has the potential for a beneficial effect on vision, whereas it might worsen the natural course of larger lesions, with most eyes undergoing enlargement, disciform transformation or RPE tear.

Original languageEnglish
Pages (from-to)1224-1232
Number of pages9
JournalGraefe's Archive for Clinical and Experimental Ophthalmology
Volume244
Issue number10
DOIs
Publication statusPublished - Oct 2006

Fingerprint

Photochemotherapy
Visual Acuity
Retinal Pigment Epithelium
verteporfin
Choroidal Neovascularization
Retreatment
Indocyanine Green
Macular Degeneration
Fluorescein
Tears
Angiography

Keywords

  • Age-related macular degeneration
  • Choroidal neovascularization
  • Photodynamic therapy
  • Retina angiomatous proliferations

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Photodynamic therapy with verteporfin for retinal angiomatous proliferation. / Boscia, Francesco; Parodi, Maurizio Battaglia; Furino, Claudio; Reibaldi, Michele; Sborgia, Carlo.

In: Graefe's Archive for Clinical and Experimental Ophthalmology, Vol. 244, No. 10, 10.2006, p. 1224-1232.

Research output: Contribution to journalArticle

Boscia, Francesco ; Parodi, Maurizio Battaglia ; Furino, Claudio ; Reibaldi, Michele ; Sborgia, Carlo. / Photodynamic therapy with verteporfin for retinal angiomatous proliferation. In: Graefe's Archive for Clinical and Experimental Ophthalmology. 2006 ; Vol. 244, No. 10. pp. 1224-1232.
@article{a23000b0833845f5918f3d7768352830,
title = "Photodynamic therapy with verteporfin for retinal angiomatous proliferation",
abstract = "Purpose: The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV). Methods: In this non-comparative, consecutive, interventional, case series, the data on 21 eyes (19 with stage 2 and two with stage 3 RAP) of 20 patients were reviewed. Serous PED occupied more than 50{\%} of the lesion in 19 eyes. PDT was performed as per TAP protocol. Biomicroscopy and fluorescein and indocyanine-green angiography were performed to evaluate anatomical results and need for retreatment. Changes from baseline in best-corrected visual acuity (BCVA), and complications, were assessed. Results: A mean of 3.5±0.9 treatments was performed. After 13.7±2.2 months, mean BCVA decreased from 20/80 to 20/174 (P=0.0063). In six eyes (28.6{\%}) BCVA remained stable, whereas in 15 eyes (71.5{\%}) it decreased. Occlusion of RAP and flattening of PED was observed in three (14.2{\%}) eyes, conversion to disciform lesion in one (4.7{\%}), and persistence of PED in 11 eyes (52.3{\%}). One eye (4.7{\%}) evolved to haemorrhagic PED, and one (4.7{\%}) toward stage 3 RAP. A tear in the retinal pigment epithelium (RPE) was observed in four eyes (19{\%}). Eleven (52.3{\%}) showed progression of leakage, six moderate leakage (28.6{\%}), and three (14.2{\%}) absence of leakage. Conclusions: Timely PDT with verteporfin in the early stages in eyes with smaller lesions has the potential for a beneficial effect on vision, whereas it might worsen the natural course of larger lesions, with most eyes undergoing enlargement, disciform transformation or RPE tear.",
keywords = "Age-related macular degeneration, Choroidal neovascularization, Photodynamic therapy, Retina angiomatous proliferations",
author = "Francesco Boscia and Parodi, {Maurizio Battaglia} and Claudio Furino and Michele Reibaldi and Carlo Sborgia",
year = "2006",
month = "10",
doi = "10.1007/s00417-005-0205-2",
language = "English",
volume = "244",
pages = "1224--1232",
journal = "Graefe's Archive for Clinical and Experimental Ophthalmology",
issn = "0721-832X",
publisher = "Springer Verlag",
number = "10",

}

TY - JOUR

T1 - Photodynamic therapy with verteporfin for retinal angiomatous proliferation

AU - Boscia, Francesco

AU - Parodi, Maurizio Battaglia

AU - Furino, Claudio

AU - Reibaldi, Michele

AU - Sborgia, Carlo

PY - 2006/10

Y1 - 2006/10

N2 - Purpose: The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV). Methods: In this non-comparative, consecutive, interventional, case series, the data on 21 eyes (19 with stage 2 and two with stage 3 RAP) of 20 patients were reviewed. Serous PED occupied more than 50% of the lesion in 19 eyes. PDT was performed as per TAP protocol. Biomicroscopy and fluorescein and indocyanine-green angiography were performed to evaluate anatomical results and need for retreatment. Changes from baseline in best-corrected visual acuity (BCVA), and complications, were assessed. Results: A mean of 3.5±0.9 treatments was performed. After 13.7±2.2 months, mean BCVA decreased from 20/80 to 20/174 (P=0.0063). In six eyes (28.6%) BCVA remained stable, whereas in 15 eyes (71.5%) it decreased. Occlusion of RAP and flattening of PED was observed in three (14.2%) eyes, conversion to disciform lesion in one (4.7%), and persistence of PED in 11 eyes (52.3%). One eye (4.7%) evolved to haemorrhagic PED, and one (4.7%) toward stage 3 RAP. A tear in the retinal pigment epithelium (RPE) was observed in four eyes (19%). Eleven (52.3%) showed progression of leakage, six moderate leakage (28.6%), and three (14.2%) absence of leakage. Conclusions: Timely PDT with verteporfin in the early stages in eyes with smaller lesions has the potential for a beneficial effect on vision, whereas it might worsen the natural course of larger lesions, with most eyes undergoing enlargement, disciform transformation or RPE tear.

AB - Purpose: The aim of this study was to evaluate the results of photodynamic therapy (PDT), using verteporfin, for subfoveal neovascular age-related macular degeneration (ARMD) with retinal angiomatous proliferation (RAP) with pigment epithelial detachment (PED) and/or choroidal neovascularization (CNV). Methods: In this non-comparative, consecutive, interventional, case series, the data on 21 eyes (19 with stage 2 and two with stage 3 RAP) of 20 patients were reviewed. Serous PED occupied more than 50% of the lesion in 19 eyes. PDT was performed as per TAP protocol. Biomicroscopy and fluorescein and indocyanine-green angiography were performed to evaluate anatomical results and need for retreatment. Changes from baseline in best-corrected visual acuity (BCVA), and complications, were assessed. Results: A mean of 3.5±0.9 treatments was performed. After 13.7±2.2 months, mean BCVA decreased from 20/80 to 20/174 (P=0.0063). In six eyes (28.6%) BCVA remained stable, whereas in 15 eyes (71.5%) it decreased. Occlusion of RAP and flattening of PED was observed in three (14.2%) eyes, conversion to disciform lesion in one (4.7%), and persistence of PED in 11 eyes (52.3%). One eye (4.7%) evolved to haemorrhagic PED, and one (4.7%) toward stage 3 RAP. A tear in the retinal pigment epithelium (RPE) was observed in four eyes (19%). Eleven (52.3%) showed progression of leakage, six moderate leakage (28.6%), and three (14.2%) absence of leakage. Conclusions: Timely PDT with verteporfin in the early stages in eyes with smaller lesions has the potential for a beneficial effect on vision, whereas it might worsen the natural course of larger lesions, with most eyes undergoing enlargement, disciform transformation or RPE tear.

KW - Age-related macular degeneration

KW - Choroidal neovascularization

KW - Photodynamic therapy

KW - Retina angiomatous proliferations

UR - http://www.scopus.com/inward/record.url?scp=33749047445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33749047445&partnerID=8YFLogxK

U2 - 10.1007/s00417-005-0205-2

DO - 10.1007/s00417-005-0205-2

M3 - Article

VL - 244

SP - 1224

EP - 1232

JO - Graefe's Archive for Clinical and Experimental Ophthalmology

JF - Graefe's Archive for Clinical and Experimental Ophthalmology

SN - 0721-832X

IS - 10

ER -